Herpes simplex virus type-1 (HSV-1) has been used for virus was reactivated by treatment of cadmium sulfate. gene delivery in the nervous system for the treatment of Viral shedding from tears was detected by incubation with brain tumors and other neurological diseases. In most proVero cells, and the trigeminal ganglia, cortical tissue and tocols, recombinant viruses containing the gene of interest the eyes were collected to detect reactivated wild-type are directly injected into the brain. Since many people virus by RT-PCR. Our results showed that while the harbor latent wild-type HSV-1 virus in sensory ganglia and reactivated wild-type virus was readily detectable in the other regions of the nervous system, there is a potential cadmium-sulfate-treated animals, intracerebrally infected risk that the injected recombinant virus may reactivate the hrR3 did not reactivate the latent virus in either the corneal latent wild-type virus to cause severe encephalitis. The model or the cerebral model. These results indicate that present study used two rat latent infection models to evaluintracranial injection of partially defective recombinant virus ate this risk. Adult rats were infected with wild-type kos by may bear little risk of reactivating latent wild-type virus cornea scarification or by intracerebral injection, and after harbored in the sensory ganglia or the brain in our anithe establishment of latency, the ICP6(−) strain hrR3 was mal model. injected intracerebrally. In the control group, the latent
Introduction
for various diseases 15, 16 (see review Ref. 17) . The most Herpes simplex virus type-1 (HSV-1) is a DNA virus common method used for the delivery of HSV-1 viral infecting a large human population. The most common vectors in both animal models and proposed clinical clinical HSV-1 infection is manifested as mucocutaneous trials is intracerebral inoculation, which involves invasive lesions caused by lytic infection with the virus, in which cranial surgery, brain tissue damage and viral infection. the virus actively replicates in the cell, expresses viral Since a majority of the human population contains the proteins causing cytopathic effects, and eventually lyses latent virus in various regions of the nervous system, the cell. While the lytic infection mostly involves epiincluding trigeminal ganglia, olfactory bulbs, amygdala, thelial cells, another process of herpes infection frehippocampus, brain stem and cerebral cortex, it is quently occurs in ganglionic neurons innervating the important to know whether the application of recombiinfected region. 1 In these neurons, a latent infection is nant HSV-1 vector will reactivate latent wild-type HSVestablished at the time of the initial infection. During the 1 virus. As a preliminary attempt to address this queslatency, the virus appears quiescent without DNA replition, we established two rat latent-infection models and cation and protein synthesis. The only detectable activity investigated whether invasive intracranial surgery and is the presence of two co-5′-terminated latency-associated massive viral infection with replication-defective HSV-1 transcripts (LATs). 2, 3 The latently infectious virus can be mutants can reactivate latent wild-type HSV-1 in both the reactivated in certain circumstances, such as stress, 4, 5 UV trigeminal ganglia and the cerebral cortex. irradiation, 6 suppression of the immune system, 7, 8 fever, 9,10 deprivation of growth factors, 11, 12 or neuronal Results injury. 13, 14 The reactivated virus resumes viral DNA replication and the expression of viral proteins, causing cyto-A total of nine rats were subjected to CdSO 4 -induced pathic effects including lysis of the cell, which may be reactivation. Among them, two were treated with CdSO 4 responsible for herpes encephalitis when the recurrent on the 31st day after the initial corneal infection, two on viral activity occurs in the central nervous system. the 44th day and the remaining five on the 144th day (see Recently, recombinant HSV-1 viruses have been exten- reactivated in rats by treatment with cadmium sulfate, which provided a positive control in the present study and can also do so for other herpes neurovirology studies. Our results also showed that the latent virus in the and three of the four animals with shorter latent infections (31 and 44 days) were also positive. The reactivation eye and/or the trigeminal ganglia could not be reactivated by a second intracerebral infection with a virus of the latent virus in CdSO 4 treated animals was also confirmed by RT-PCR from the total RNA of the trigeminal defective either in thymidine-kinase gene or in that for ribonucleotide reductase. Furthermore, we showed that ganglia, in which the messenger RNA of thymidine kinase was detected in a total of seven out of nine animals.
no reactivated wild-type virus could be detected even in a situation where the wild-type virus was initially In another group, 13 rats with latent infection of wildtype kos strain in the right eye received a second viral injected intracerebrally and the second virus was injected directly at the same location. infection intracerebrally with replication-defective strains. Among them, 11 were injected with hrR3 and the Cadmium sulfate treatment was reported to have the ability to reactivate latent viral infection in mice by Fawl other two were injected with tkSB strain. Although the viral infection was readily detectable in the injection and Roizman. 18 The present study reports a rat model using the same method. While the mechanism of CdSO 4 -regions of the brain by either X-gal/␤-galactosidase reaction or immunocytochemistry for viral antigens (data not induced viral reactivation is not clear, the neurotoxic effects of heavy-metal ions may play a role, as symptoms shown), no viral shedding was detected in tear samples from those animals. To determine whether the latently of damage in the nervous system were developed in animals 2 days after the CdSO 4 treatment. Using the current infected wild-type virus in the trigeminal ganglia could be reactivated by the second intracerebral viral injection, dosage, no animal died within 6 days and most of them showed the reactivation of latent virus, demonstrating on day 3 (six animals) or day 4 (seven animals) after intracerebral inoculation, messenger RNAs of thymidine that this is a reliable model for the study of viral reactivation as well as a positive control for the present study. kinase or ribonucleotide reductase for tkSB-and hrR3-injected animals, respectively, were measured with RTBoth tk(−) and ICP6(−) viral strains are partially defective in replication. 19, 20 Thymidine kinase phosphorylates PCR in ganglion samples. While the wild-type mRNAs of both genes were readily detectable in ganglia taken nucleotides and ribonucleotide reductase reduces ribonucleotides to their corresponding deoxyribonucleotides. from CdSO 4 -treated animals, neither of them could be detected in animals that received the second infection Both enzymes provide important pathways in DNA synthesis. In rapidly dividing cells, cellular kinases and suggesting no activity of the latent wild-type virus initially infected through the cornea after intracerebral ribonucleotide reductase are active, and probably a sufficient number of phosphorylated and reduced ribonucleviral injection (Figure 1) .
A total of seven animals were intracerebrally infected otide precursors are available for viral DNA synthesis, which allows the replication of the mutants to appear with 5 × 10 4 p.f.u. of wild-type kos HSV-1. Our preliminary experiment showed that Long-Even rats were tolernormal. 21, 22 However, in postmitotic cells such as neuronal cells, both viral enzymes are essential for viral repliant of the intracerebral infection at this titer. The animals appeared asymptomatic and no significant encephalitis cation, as the virus depends on production of its own precursors for DNA synthesis. Both mutants therefore or viral antigens could be detected in the brain by immunohistological examination 14 days after the inoculation appear much less neurovirulent in the brain 23, 24 and have been used recently as vectors for experimental gene ther-(data not shown). These animals were given a second injection of either hrR3 (four animals) or medium (three apy for brain tumors. 8, 16, [25] [26] [27] Although many studies have suggested that wild-type animals) at the same stereotactic coordinates 40 days after the initial injection. Four days after the second infection, HSV-1 is readily reactivated by several factors including stress and neuronal damage, our results show that a total RNA and DNA extracted from cortical tissue near the injection site were used for RT-PCR. In animals second injection of mutant virus into the brain failed to reactivate the latent virus initially infected either corinjected with hrR3 virus, expression of ␤-galactosidase was confirmed by both X-gal staining and RT-PCR using neally or intracerebrally. Since the corneal-infected virus establishes latency in the trigeminal ganglion, which is primers for the lacZ gene. However, we failed to detect
Figure 1 Total RNA of the eyes from animals latently infected with kos HSV-1 (corneal infection in the right eye) were extracted and used for RT-PCR to detect mRNA of tk gene following either repeated treatment of CdSO 4 or cerebral infection with HSV-1 mutant hrR3. Results from two cerebral infected animals and one CdSO 4 -treated animal are shown in the Figure. While a band of 1224 bp of RT-PCR product from tk mRNA was detected in the eye from the CdSO 4 -treated animal, no expression of the tk gene was detected in the eyes from the animals with the hrR3 infection in the brain. The last lane showed a PCR product amplified from the tk region in the HSV-1 genome (kos) using the same primers.
the most common site for latent herpes viruses in other approaches including transplantation also largely failed to reactivate the virus in the CNS. 29, 30 Our prelimihumans, this model probably mimics the most common clinical situation. Due to the deficiency in replication of nary experiments also failed to reactivate cerebrally infected wild-type HSV-1 in rats treated with CdSO 4 the hrR3 strain injected in the cerebral cortex, it is unlikely that the cerebrally injected virus can pass several (data not shown). Nevertheless, failure to detect any reactivation of latent synapses to infect the neurons in the trigeminal ganglia. Thus, the significance of using a corneal latent model is wild-type HSV-1 virus by secondary injection of replication-defective mutants supports the safety of this that it tests the effects of traumatic stress caused by cranial surgery and massive viral infection on latently approach to using HSV-1 vectors for potential gene therapies. However, one can not rule out the possibility that infected virus in the trigeminal ganglia. It is apparent that rats were well tolerant of this kind of stress, as neither secondarily infected hrR3 may not access the same cells as the latent wild-type virus or the possibility that hrR3 viral nor medium injections in the cortex could reactivate the latent virus in the trigeminal ganglia under these virus may not provide optimal conditions for reactivation of the latent virus in the neurons. Further investigations experiment conditions. The intracerebral-latency model provided an extreme situation where the recombinant using different mutant viral strains and other animal models are necessary to generalize the conclusions drawn virus was injected into a cortical region in which neurons hosted the latent wild-type virus. Despite a much higher from the present study. viral titer and an apparently larger infected area in the second infection compared with the first one, the second
Materials and methods
infection did not reactivate the primary infected wildtype virus. It seems unlikely that this is due to lack of Viruses certain viral proteins that are required for reactivation Wild-type kos strain of HSV-1 virus was used to establish but not expressed in hrR3, as all viral proteins except the latent-infection models. For intracerebral inoculation, ribonucleotide reductase are expressed in hrR3-infected ribonucleotide reductase defective HSV-1 (hrR-3; gift Vero cells. 19 Although there is no definite evidence that from S Weller, Department of Microbiology, University all the viral genes in hrR3 were still expressed in vivo, it of Connecticut Health Center, CT, USA) and thymidineis probably true that at least some immediate-early genes kinase defective HSV-1 (tkSB; gift from J Smiley, Departwere expressed, given the fact that the lacZ gene was ment of Pathology, McMaster University, Ontario, expressed in hrR3-infected brains. The lacZ gene is Canada) were used. inserted in the ICP6 region and is controlled by the ICP6 promoter, which is regulated by the activity of immediViral infection ate-early genes ICP0 and ICP27. 19, 28 It is more likely that cortical neurons are not favorable hosts for reactivation Eye infection: Adult male Long-Even rats were infected with 5 l of wild-type kos HSV-1 (10 7 p.f.u./ml) in of latently-infected HSV-1, as some early studies using (three animals) was injected at the same stereotactic coordinates. Four days after the second viral injection, the animals were killed and the brain tissue was collected for immunocytochemistry and RT-PCR.
Drug-induced reactivation of latent virus: After the establishment of latency, animals in the positive control group were treated with cadmium sulfate (3.5 g per gram body weight) subcutaneously once a day for 4 days before being killed.
Detection of reactivated virus
Viral shedding in tears: Starting from the day of either infection with recombinant virus or treatment with cadmium sulfate, tears from both eyes were collected daily with strips of sterilized filter paper for 4 days. The paper strips were then incubated for 2 h at 37°C in 200 l of Dulbecco's modified Eagle's medium (DMEM), which was then plated on Vero cell monolayers for plaque assays.
Virus in eyes and ganglia: On the fifth day following the second infection or cadmium sulfate treatment, animals were killed to collect the eyes, the trigeminal ganglia and eye, trigeminal ganglia and brain after reactivation. The total RNAs were extracted with TRIZOL (Gibco BRL, Burlington, Ontario, Canada) from crude tissue homomedium by corneal inoculation in the right eye. After the initial infection, various times from 31 days to a few genate and precipitated in isopropanol. Samples were then treated with DNase I followed by reverse transcripmonths were allowed to elapse to allow the establishment of latency before a second infection was performed.
tion and PCR. The primers used for the RT-PCR are shown in Table 2 . For the secondary infection, 10 7 p.f.u. in 5 l medium of a recombinant HSV-1 mutant, either hrR3 or tkSB was PolyT-17 or random hexamer primer from Clontech (Palo Alto, CA, USA) were used in the reverse transcripinjected intracerebrally, using stereotactic coordinates at bregma (1 mm), lateral (2 mm) and vertical (3 mm) from tion of thymidine kinase messenger RNA and a 20-base primer complementary to a sequence 80 bp downstream the top of the scull.
of the PCR target region was used in the reverse transcription of ribonucleotide reductase (Table 2 ). For PCR, Repeated brain infection: A total of seven rats were initially injected with 5 × 10 4 p.f.u. in 5 l medium of primers were designed to amplify either a 357 bp region for HSV-1tk or a 237 bp region for ICP6. In order to diswild-type kos HSV-1 into the frontal cerebral cortex, using the above stereotactic coordinates. The animals tinguish the wild-type ICP6 from the recombinant one, the target sequence in the ICP6 region was designed to were allowed to establish latency for 40 days before either the hrR3 mutant (four animals, 10 7 p.f.u. in 20 l contain the BamHI site, at which the ␤-galactosidase gene was inserted in the recombinant strain hrR3. 19 To allow medium over 2.5 h) or the same volume of medium 
